Quantum Biopharma Ltd. (QNTM) research
Quantum Biopharma Ltd.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.20
- As of
Share the QNTM intelligence card
See QNTM live in the terminal
Track QNTM's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live QNTM terminal, freeActive signals for QNTM
- mediumEARNINGS_BEAT
Q4-2020: Beat consensus by 76.3% - EPS $-22.035 vs $-92.82 estimate
- mediumEARNINGS_BEAT
Q2-2020: Beat consensus by 40.8% - EPS $-43.55 vs $-73.593 estimate
- mediumEARNINGS_BEAT
Beat consensus by 76.3% - EPS $-22.035 vs $-92.82 estimate
- mediumEARNINGS_BEAT
Beat consensus by 40.8% - EPS $-43.55 vs $-73.593 estimate
- mediumEARNINGS_MISS
Q3-2020: Missed consensus by 87.9% - EPS $-89.05 vs $-47.4045 estimate
FREE, NO ACCOUNT
Every signal on QNTM, as it fires
New filings, 13F moves and cross asset signals on QNTM land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in QNTM (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 74764Y205 · 2026Q2 | $57K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, QNTM
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Related tickers
See more QNTM signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to QNTMand get the insider, 13F, options, and confluence read in one view.